Mesoblast Ltd

Biotechnology company · Melbourne, Victoria, Victoria, Australia · Nasdaq: MESO

Mesoblast Ltd is a biotechnology company headquartered in Melbourne, Victoria, Victoria, Australia. Its shares trade on Nasdaq under the ticker MESO. It has reported private securities offerings to the US SEC, most recently $6.5 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Mesoblast at a glance

Typebiotechnology company

HeadquartersMelbourne, Victoria, Victoria, Australia

Stock listingNasdaq: MESO

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1345099

What does Mesoblast do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $6.5 million sold (2020).

Frequently asked questions about Mesoblast

Where is Mesoblast headquartered?

Mesoblast Ltd is headquartered in Melbourne, Victoria, Victoria, Australia.

What does Mesoblast do?

Mesoblast Ltd is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Mesoblast a public company?

Yes. Mesoblast Ltd trades on Nasdaq under the ticker MESO.

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.